Bio-Thera Solutions, Ltd. (SHA:688177)
23.70
-0.16 (-0.67%)
At close: Feb 13, 2026
Bio-Thera Solutions Market Cap
Bio-Thera Solutions has a market cap or net worth of 9.81 billion as of February 13, 2026. Its market cap has increased by 26.06% in one year.
Market Cap
9.81B
Enterprise Value
10.20B
Revenue
845.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.70
Market Cap Chart
Since February 21, 2020, Bio-Thera Solutions's market cap has decreased from 24.93B to 9.81B, a decrease of -60.63%. That is a compound annual growth rate of -14.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 9.81B | 2.42% |
| Dec 31, 2025 | 9.58B | 19.40% |
| Dec 31, 2024 | 8.02B | -53.01% |
| Dec 29, 2023 | 17.08B | 89.35% |
| Dec 30, 2022 | 9.02B | -15.68% |
| Dec 31, 2021 | 10.70B | -18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 11.01B |
| Aurisco Pharmaceutical | 10.78B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.68B |
| Liaoning Chengda Biotechnology | 10.54B |
| Chengzhi | 10.44B |
| Chongqing Genrix Biopharmaceutical | 10.41B |
| Youcare Pharmaceutical Group | 9.42B |
| Chengdu Kanghua Biological Products | 9.28B |